|
This page summarised some of the reasons why we need EBM. It addresses:
In selecting treatments for patients, until recently it had been considered sufficient to understand the pathophysiological process in a disorder and to prescribe drugs or other treatments that had been shown to interrupt or modify this process. For example, the observation that patients with ventricular ectopic beats following myocardial infarction were at high risk of sudden death [1]. However, subsequent randomised controlled trials examined hard clinical outcomes, not physiologic processes, and showed that several of these drugs increase, rather than decrease, the risk of death in such patients, and their routine use is now strongly discouraged [2]. Other randomised trials (their total number now between 250,000 and 1,000,000!) have confirmed the efficacy of many treatments and confirmed the uselessness or harmfulness of many others. And a still more recent methodology, the systematic review or overview (when it uses specific sorts of statistics it’s called a meta-analysis) has permitted us to draw even firmer conclusions by combining all the proper randomised trials on an issue in health care. Equally powerful methods have been developed and applied to determine the validity and usefulness of the clinical history and physical examination, diagnostic tests, and prognostic markers. For example, there are more than 30 bits of the history and physical examination that we could pursue (and often are taught to do so!) in deciding whether a patient had chronic airflow limitation. But when these bits are subjected to rigorous evaluation for their precision and accuracy, the emerging evidence reveals that most of them either bear no relation to simultaneous physiological measurements (such as peak flows or FEV1 ) or can’t be confirmed on repeat examination, even by the same clinician! The bottom line is that there are some specific items of the history and physical exam that are very precise and accurate in the bedside diagnosis of chronic airflow limitation, and clinicians who know them and can integrate them with their other knowledge and judgement will be better, faster clinicians than their peers. Clinicians who keep up to date with these advances in knowledge practice better medicine. Unfortunately, most of us don’t. Given the extremely rapid growth of randomised trials and other rigorous clinical investigations, the issue is no longer how little of medical practice has a firm basis in such evidence; the issue today is how much of what is firmly based is actually applied in the front lines of patient care.
A study of North American general physicians found that they reported a need for new and clinically important information just once or twice a week. However, subsequent "shadowing" and direct questioning of the same group revealed two such information needs for every three new patients they saw. [3] The clinicians cited three main barriers between them and the information they needed:
The clinical literature is now so big that general physicians who want to keep abreast of the journals relevant to their practices have to examine 19 articles a day, 365 days a year [4]. Even self-reports of median reading times shown that there is simply no way that clinicians have enough time to read all the journals relevant to them. The table below summarises Dave Sackett's polls of medical grand rounds audiences at a number of UK medical schools:
It is clear from the foregoing that we need far readier access to clinically important information. No wonder, then, that there is increasing interest in providing, and even requiring, Continuing Medical Education (CME), Continuing Professional Development, and the like. But when the same powerful strategy for determining the efficacy of a therapeutic regimen - the randomised controlled trial - has been used to test the efficacy of CME, the results have been sobering. Systematic reviews of the relevant randomised trials have shown that traditional, instructional CME simply fails to modify our clinical performance and is ineffective in improving the health outcomes of our patients [8,9].
|
|||||||||||||||||||||||||||||||